Latest filing published 09 Dec 2021 for Recursion Pharmaceuticals, INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lux Ventures IV, L.P.: trading record in brief
Lux Ventures IV, L.P. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Recursion Pharmaceuticals, Inc. and Latch, Inc. In total, 7 filings cover trades dated from 16 April 2021 to 7 December 2021.
Purchases make up the whole of the open-market record (1 purchase, €1.5M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 9 December 2021: a transaction, in Recursion Pharmaceuticals, Inc. The last purchase on record was published on 20 April 2021, which is 2,028 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lux Ventures IV, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,265,576 shares0Class A common stockSEC:0000905718-21-001582:0
- 2,409,489 shares0Common StockSEC:0000905718-21-001276:0
2 of 2 declarations
